PRESCRIPTION DRUG ETHICAL MARK
Summary
Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in Illinois authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose.
Bill status
failed
1 of 4 stages cleared
Introduction
Jan 2004
Committee Review
Floor Vote
Governor
Introduced Jan 27, 2004
Last action Jan 11, 2005
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
19
Key actions
0
Committee
4
Jan 11, 2005
House · Failed
Session Sine Die
Apr 2, 2004
House · Referred to committee
Rule 19(a) / Re-referred to Rules Committee
Feb 25, 2004
House · Reported by committee
Do Pass / Short Debate State Government Administration Committee; 007-001-002
Feb 19, 2004
House · Referred to committee
Assigned to State Government Administration Committee
Jan 30, 2004
House · Referred to committee
Referred to Rules Committee
0 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
Co
Jack D. Franks
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 4233
Scope: IL
Hi! I can help you understand HB 4233. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline